Agilent Technologies (A) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Agilent Technologies · Health Care · ref. ETF XLV · 73 calls · price $171.6
What the company does: Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries.
📈 Agilent Technologies (A) stock price
$171.6+24.3% over range
Oct 14, 25low $110.24 · high $175.21Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
88% recommend buying · 16 analysts
📊 JPI status : Agilent Technologies has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 A price target & analyst consensus — price $172
The price target · all analysts combined (15 targets)
Highest target · 1 firm of 15$195+13.6%
Median target · of 15 targets$180+4.9%
Lowest target · 1 firm of 15$150-12.6%
Current price$171.6
Where these 15 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
1280%
$172 ↔ $196
Below
320%
$150 ↔ $165
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Bernstein — 69% of its targets hit on this sector (70 calls tested). It aims for $180 (+4.9 %), call made on August 28, 2026, maturing on August 28, 2027 (47 d ago).
The 9 reliable analysts
$180+4.9 %
The 6 other firms
$175+2.0 %
How to read it: the 9 reliable firms are not filtered by optimism — 9 aim above the price, 0 below, hence their $180 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 16 ratings (last 6 months)
Strong Buy00%
Buy1488%
Hold213%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 A price target all
All 15 calls, one by one, with our verdict on each firm.
→ See all 15 targets, analyst by analyst💡 The best analysts on A most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in A? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Agilent Technologies? The JPI assistant answers using our backtest data.
💰 Agilent Technologies dividend: yield, history & growth › open the full page
0.95%annual yield
That's ~$1.26 per share per year.
📈 Agilent Technologies fundamentals: valuation, margins & growth › open the full page
P/E 33.8Net margin 19.5 %Revenue growth +8.1 %High P/E
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 18 %
2023
Rev −0%Profit −1%
2024
Rev −5%Profit +4%
2025
Rev +7%Profit +1%
🔎 Detailed analyses
✅ Historical analyst reliability on A
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| ISI Group | 100% | +20.1% | 4 |
| Morgan Stanley ↗ | 86% | +10.4% | 14 |
| Wells Fargo ↗ | 78% | +21.5% | 18 |
| Goldman Sachs ↗ | 78% | +18.1% | 9 |
| Deutsche Bank ↗ | 75% | +8.9% | 4 |
| Jefferies ↗ | 71% | +14.3% | 14 |
| Cowen & Co. | 71% | +8.7% | 7 |
| Stifel ↗ | 71% | +8.5% | 7 |
| JP Morgan ↗ | 69% | +11.2% | 13 |
| SVB Leerink | 67% | +17.1% | 12 |
See the other 11 firms
| SVB Securities | 29% | -3.6% | 7 |
| Keybanc ↗ | 29% | -3.3% | 7 |
| BTIG ↗ | 50% | +10.1% | 2 |
| TD Cowen ↗ | 55% | +6.3% | 11 |
| B of A Securities ↗ | 60% | +3.4% | 15 |
| UBS ↗ | 60% | +9.6% | 10 |
| Evercore ISI Group ↗ | 60% | +11.6% | 5 |
| Credit Suisse | 60% | +12.6% | 5 |
| Baird ↗ | 61% | +12.8% | 23 |
| Citigroup ↗ | 64% | +9.7% | 11 |
| Barclays ↗ | 67% | +10.6% | 18 |
📊 What $1,000 invested in Agilent Technologies would be worth › open the full page
In short — $1,000 invested in Agilent Technologies 10 years ago would be worth $3,177 today, i.e. +12%/yr on average. Best year: 2017 (+47%), worst: 2023 (-7%). Price performance, excluding dividends.
If I'd invested $1,000 in Agilent Technologies
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $989 | -1% |
| 3 years ago | $888 | -11% |
| 5 years ago | $1,121 | +12% |
Return by year (Agilent Technologies)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -2% | $976 (-2%) |
| 2025 | +1% | $989 (-1%) |
| 2024 | -3% | $955 (-4%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Agilent Technologies
Loading news…
📋 All analyst calls on A
Filtered on — · ✕ show all
▲ Buy · 🎯$196
Today : $171.6 — upside +14%
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Oct 13, 27
matures : Oct 13, 27
Morgan Stanley ↗
Oct 13, 26
▲ Overweight · 🎯$190
Today : $171.6 — upside +11%
🎯 on A : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Oct 13, 27
matures : Oct 13, 27
▲ Overweight · 🎯$195
Price at call : $169.09 — upside +15%
Today : $171.6 — upside +14%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
Wells Fargo ↗
Aug 28, 26
▲ Overweight · 🎯$180
Price at call : $153.84 — upside +17%
Today : $171.6 — upside +5%
🎯 on A : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Aug 28, 27
matures : Aug 28, 27
▲ Buy · 🎯$180
Price at call : $153.84 — upside +17%
Today : $171.6 — upside +5%
🎯 on A : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
B of A Securities ↗
Aug 27, 26
▲ Buy · 🎯$180
Price at call : $153.84 — upside +17%
Today : $171.6 — upside +5%
🎯 on A : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
▲ Buy · 🎯$190
Price at call : $153.84 — upside +24%
Today : $171.6 — upside +11%
🎯 on A : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
Goldman Sachs ↗
Aug 27, 26
▲ Buy · 🎯$175
Price at call : $153.84 — upside +14%
Today : $171.6 — upside +2%
🎯 on A : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
See the other 65 calls, newest to oldest
▲ Overweight · 🎯$190
Price at call : $153.84 — upside +24%
Today : $171.6 — upside +11%
🎯 on A : 100% (1 call matured) · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
▲ Buy · 🎯$180
Price at call : $153.84 — upside +17%
Today : $171.6 — upside +5%
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
▲ Outperform · 🎯$180
Price at call : $153.84 — upside +17%
Today : $171.6 — upside +5%
🎯 on A : no call matured yet · 📊 on Health : 55.7% · +5.7% (70 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
RBC Capital ↗
Aug 27, 26
▲ Outperform · 🎯$185
Price at call : $153.84 — upside +20%
Today : $171.6 — upside +8%
🎯 on A : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
Evercore ISI Group ↗
Aug 27, 26
▲ Outperform · 🎯$172
Price at call : $157.69 — upside +9%
Today : $171.6 — upside +0%
🎯 on A : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
▲ Overweight · 🎯$175
Price at call : $157.69 — upside +11%
Today : $171.6 — upside +2%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
Morgan Stanley ↗
Aug 12, 26
▲ Overweight · 🎯$175
Price at call : $149.29 — upside +17%
Today : $171.6 — upside +2%
🎯 on A : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Aug 12, 27
matures : Aug 12, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$148
Price at call : $131.14 — upside +13%
Today : $171.6 — upside -14%
🎯 on A : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
▲ Overweight · 🎯$150
Price at call : $135.51 — upside +11%
Today : $171.6 — upside -13%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jun 24, 27
matures : Jun 24, 27
Piper Sandler ↗
Jun 11, 26
■ Neutral neutral · not a buy · 🎯$150
Price at call : $129.55 — gap to target +16%
Today : $171.6 — gap to target -13%
🎯 on A : no call matured yet · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Jun 11, 27
matures : Jun 11, 27
▲ Buy · 🎯$165
Price at call : $138.37 — upside +19%
Today : $171.6 — upside -4%
🎯 on A : no call matured yet · 📊 on Health : 55.2% · +1.7% (29 calls)
in progress (365j)
matures : Jun 3, 27
matures : Jun 3, 27
B of A Securities ↗
Jun 2, 26
▲ Buy · 🎯$155
Price at call : $137.4 — upside +13%
Today : $171.6 — upside -10%
🎯 on A : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Jun 2, 27
matures : Jun 2, 27
RBC Capital ↗
May 28, 26
▲ Outperform · 🎯$155
Price at call : $135.53 — upside +14%
Today : $171.6 — upside -10%
🎯 on A : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
▲ Buy · 🎯$155
Price at call : $135.53 — upside +14%
Today : $171.6 — upside -10%
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
▲ Overweight · 🎯$145
Price at call : $135.53 — upside +7%
Today : $171.6 — upside -16%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
Wells Fargo ↗
May 28, 26
▲ Overweight · 🎯$160
Price at call : $135.53 — upside +18%
Today : $171.6 — upside -7%
🎯 on A : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
B of A Securities ↗
May 28, 26
▲ Buy · 🎯$145
Price at call : $135.38 — upside +7%
Today : $171.6 — upside -16%
🎯 on A : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
RBC Capital ↗
May 27, 26
▲ Outperform · 🎯$153
Price at call : $135.38 — upside +13%
Today : $171.6 — upside -11%
🎯 on A : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : May 27, 27
matures : May 27, 27
▲ Outperform · 🎯$156
Price at call : $115.08 — upside +36%
Today : $171.6 — upside -9%
🎯 on A : 42% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : May 26, 27
matures : May 26, 27
■ Sector Weight neutral · not a buy
🎯 on A : no call matured yet · 📊 on Health : 43.4% · -1.8% (145 calls)
in progress (365j)
matures : Apr 28, 27
matures : Apr 28, 27
▲ Overweight · 🎯$140
Price at call : $119.77 — upside +17%
Today : $171.6 — upside -18%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Apr 14, 27
matures : Apr 14, 27
▲ Buy · 🎯$147
Price at call : $117.5 — upside +25%
Today : $171.6 — upside -14%
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
Evercore ISI Group ↗
Apr 6, 26
▲ Outperform · 🎯$140
Price at call : $113.88 — upside +23%
Today : $171.6 — upside -18%
🎯 on A : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
Morgan Stanley ↗
Mar 3, 26
▲ Overweight · 🎯$160
Price at call : $120.54 — upside +33%
Today : $171.6 — upside -7%
🎯 on A : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Mar 3, 27
matures : Mar 3, 27
▲ Buy · 🎯$165
Price at call : $121.38 — upside +36%
Today : $171.6 — upside -4%
🎯 on A : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Buy · 🎯$157
Price at call : $121.38 — upside +29%
Today : $171.6 — upside -9%
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
Wells Fargo ↗
Feb 26, 26
▲ Overweight · 🎯$165
Price at call : $121.38 — upside +36%
Today : $171.6 — upside -4%
🎯 on A : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Overweight · 🎯$150
Price at call : $121.38 — upside +24%
Today : $171.6 — upside -13%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Buy · 🎯$180
Price at call : $135.83 — upside +33%
Today : $171.6 — upside +5%
🎯 on A : no call matured yet · 📊 on Health : 55.2% · +1.7% (29 calls)
in progress (365j)
matures : Jan 20, 27
matures : Jan 20, 27
Evercore ISI Group ↗
Jan 5, 26
▲ Outperform · 🎯$160
Price at call : $147.6 — upside +8%
Today : $171.6 — upside -7%
🎯 on A : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
▲ Overweight · 🎯$165
Price at call : $140.6 — upside +17%
Today : $171.6 — upside -4%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
Goldman Sachs ↗
Dec 9, 25
▲ Buy · 🎯$170
Price at call : $140.64 — upside +21%
Today : $171.6 — upside -1%
🎯 on A : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
Morgan Stanley ↗
Dec 2, 25
▲ Overweight · 🎯$180
Price at call : $149.26 — upside +21%
Today : $171.6 — upside +5%
🎯 on A : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
▲ Buy · 🎯$185
Price at call : $154.37 — upside +20%
Today : $171.6 — upside +8%
🎯 on A : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Nov 25, 26
matures : Nov 25, 26
▲ Buy · 🎯$180
Price at call : $154.37 — upside +17%
Today : $171.6 — upside +5%
🎯 on A : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Nov 25, 26
matures : Nov 25, 26
Wells Fargo ↗
Nov 25, 25
▲ Overweight · 🎯$175
Price at call : $154.37 — upside +13%
Today : $171.6 — upside +2%
🎯 on A : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Nov 25, 26
matures : Nov 25, 26
▲ Overweight · 🎯$180
Price at call : $154.37 — upside +17%
Today : $171.6 — upside +5%
🎯 on A : 100% (1 call matured) · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Nov 25, 26
matures : Nov 25, 26
■ Equal-Weight neutral · not a buy · 🎯$165
Price at call : $154.37 — gap to target +7%
Today : $171.6 — gap to target -4%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Nov 25, 26
matures : Nov 25, 26
▲ Outperform · 🎯$165
Price at call : $157.2 — upside +5%
Today : $171.6 — upside -4%
🎯 on A : 42% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Nov 25, 26
matures : Nov 25, 26
B of A Securities ↗
Nov 25, 25
■ Neutral neutral · not a buy · 🎯$165
Price at call : $157.2 — gap to target +5%
Today : $171.6 — gap to target -4%
🎯 on A : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Nov 25, 26
matures : Nov 25, 26
▲ Buy · 🎯$162
Price at call : $138.04 — upside +17%
Today : $171.6 — upside -6%
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Oct 14, 26
matures : Oct 14, 26
▲ Overweight · 🎯$165
Price at call : $140.11 — upside +18%
Today : $171.6 — upside -4%
Expected +18% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on A : 100% (1 call matured) · 📊 on Health : 53.8% · +5.2% (364 calls)
+21.7%
stock +22% · XLV +18%
matured Oct 9, 26
▲ Outperform · 🎯$142
Price at call : $125.66 — upside +13%
Today : $171.6 — upside -17%
Expected +13% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on A : 42% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+22.2%
stock +22% · XLV +24%
matured Aug 28, 26
▲ Outperform · 🎯$140
Price at call : $108.53 — upside +29%
Today : $171.6 — upside -18%
Expected +29% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on A : 42% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+6.0%
stock +6% · XLV +14%
matured May 22, 26
▲ Outperform · 🎯$159
Price at call : $127.08 — upside +25%
Today : $171.6 — upside -7%
Expected +25% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on A : 42% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-4.5%
stock -4% · XLV +9%
matured Feb 27, 26
▲ Buy · 🎯$160
Price at call : $140.87 — upside +14%
Today : $171.6 — upside -7%
Expected +14% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 48% · +0.6% (98 calls)
-15.4%
stock -15% · XLV -12%
matured Aug 22, 25
▲ Buy · 🎯$153
Price at call : $130.41 — upside +17%
Today : $171.6 — upside -11%
Expected +17% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 48% · +0.6% (98 calls)
-14.8%
stock -15% · XLV -8%
matured May 30, 25
▲ Outperform · 🎯$136
Price at call : $131.42 — upside +3%
Today : $171.6 — upside -21%
Expected +3% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on A : 42% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-14.8%
stock -15% · XLV -6%
matured May 30, 25
▲ Outperform · 🎯$147
Price at call : $139.2 — upside +6%
Today : $171.6 — upside -14%
Expected +6% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on A : 42% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-24.6%
stock -25% · XLV -4%
matured Apr 22, 25
▲ Outperform · 🎯$130
Price at call : $123.92 — upside +5%
Today : $171.6 — upside -24%
Expected +5% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on A : 42% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+3.8%
stock +4% · XLV +10%
matured Nov 20, 24
▲ Outperform · 🎯$147
Price at call : $120.85 — upside +22%
Today : $171.6 — upside -14%
Expected +22% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 48% · +0.6% (98 calls)
+15.9%
stock +16% · XLV +15%
matured Aug 15, 24
▲ Outperform · 🎯$140
Price at call : $121.36 — upside +15%
Today : $171.6 — upside -18%
Expected +15% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on A : 42% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+15.3%
stock +15% · XLV +14%
matured Aug 15, 24
▲ Outperform · 🎯$145
Price at call : $120.99 — upside +20%
Today : $171.6 — upside -16%
Expected +20% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 48% · +0.6% (98 calls)
+24.4%
stock +24% · XLV +12%
matured May 23, 24
▲ Outperform · 🎯$144
Price at call : $120.99 — upside +19%
Today : $171.6 — upside -16%
Expected +19% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on A : 42% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+24.4%
stock +24% · XLV +12%
matured May 23, 24
▲ Outperform · 🎯$174
Price at call : $141.67 — upside +23%
Today : $171.6 — upside +1%
Expected +23% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on A : 42% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-1.8%
stock -2% · XLV +15%
matured Feb 29, 24
▲ Outperform · 🎯$168
Price at call : $155.35 — upside +8%
Today : $171.6 — upside -2%
Expected +8% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 48% · +0.6% (98 calls)
-18.5%
stock -18% · XLV -4%
matured Nov 22, 23
▲ Outperform · 🎯$170
Price at call : $155.35 — upside +9%
Today : $171.6 — upside -1%
Expected +9% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on A : 42% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-18.5%
stock -18% · XLV -4%
matured Nov 22, 23
▲ Outperform · 🎯$160
Price at call : $139.97 — upside +14%
Today : $171.6 — upside -7%
Expected +14% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 48% · +0.6% (98 calls)
-14.8%
stock -15% · XLV +1%
matured Aug 17, 23
▲ Outperform · 🎯$160
Price at call : $142.29 — upside +12%
Today : $171.6 — upside -7%
Expected +12% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on A : 42% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-15.1%
stock -15% · XLV +0%
matured Aug 17, 23
▲ Outperform · 🎯$161
Price at call : $120.38 — upside +34%
Today : $171.6 — upside -6%
Expected +34% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on A : 42% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-0.7%
stock -1% · XLV -3%
matured May 25, 23
▲ Outperform · 🎯$178
Price at call : $128.15 — upside +39%
Today : $171.6 — upside +4%
Expected +39% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 48% · +0.6% (98 calls)
+10.2%
stock +10% · XLV +1%
matured Feb 23, 23
▲ Outperform · 🎯$187
Price at call : $152.97 — upside +22%
Today : $171.6 — upside +9%
Expected +22% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 48% · +0.6% (98 calls)
+2.6%
stock +3% · XLV +4%
matured Nov 23, 22
▲ Outperform · 🎯$150
Price at call : $148.82 — upside +1%
Today : $171.6 — upside -13%
Expected +1% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 48% · +0.6% (98 calls)
-19.0%
stock -19% · XLV +1%
matured Jul 1, 22
▲ Outperform · 🎯$95
Price at call : $86.13 — upside +10%
Today : $171.6 — upside -45%
Expected +10% · Actual +55% · Reason (≥ +15%) : ✓ Yes
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 48% · +0.6% (98 calls)
+54.8%
stock +55% · XLV +25%
matured May 22, 21
Frequently asked questions
Should I buy Agilent Technologies stock?
This isn't buy advice. For Agilent Technologies, the analyst consensus is "Buy", with an average price target of $180 (+5% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (4 calls tracked on Agilent Technologies). We show the numbers — you decide.
Is it too late to buy Agilent Technologies? How high can it go?
The most bullish analyst target on Agilent Technologies is $195 (+14% above today's price); the average is $180. That's the upside they see. Check how reliable those analysts have actually been on Agilent Technologies on our site before trusting it.
Is Agilent Technologies still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 21 analysts have a real record on Agilent Technologies, the best hitting 100% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Agilent Technologies? The case for and against
The arguments for and against, one by one, from the numbers: why invest in A (and why hesitate).
What has Agilent Technologies's past performance been?
Historical returns and a "how much if I had invested" calculator: A performance & returns.
Does Agilent Technologies pay a dividend?
Yield, consistency and growth history of the dividend: A's dividend.
What is the best month to buy A?
The 12 months ranked by the stock's past returns: best & worst month to buy A.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX